Yoga practice and frequency improved self-reported cognitive problems among breast cancer survivors
the ONA take:
Cancer survivors often report cognitive problems. In addition, physical activity decreases over the course of cancer treatment. Cognitive function is improved with physical activity in noncancer populations; however, evidence of a link between physical activity and cognition among patients with cancer is limited.
A recent randomized, controlled trial investigated the impact of a yoga intervention on fatigue and inflammation among breast cancer survivors. In the parent trial, 200 posttreatment survivors of breast cancer stage 0-IIIa were randomized to a 12-week Hatha yoga intervention or a wait list control group. Those in the intervention group attended twice-weekly yoga sessions.
Cognitive complaints were self-reported via the Breast Cancer Prevention Trial Cognitive Problems Scale at baseline, immediately postintervention, and at 3-month follow-up. In this secondary analysis, no significant difference was seen between the groups immediately postintervention. However, the yoga participants’ scores on the self-report Scale were an average of 3% lower than those of the wait list participants at the 3-month follow-up.
Furthermore, those who practiced yoga more frequently reported significantly fewer cognitive problems that those who practiced less frequently. The researchers conclude that yoga can effectively reduce cognitive complaints among survivors of breast cancer.
Recent trial investigated impact of yoga intervention on fatigue and inflammation in breast cancer survivors.
Sign Up for Free e-newsletters
- Resolving Vaginal Dryness in Women With a History of Breast Cancer
- FDA Issues Warning for Rolapitant Injectable Emulsion in the Treatment of CINV
- Risk Factors for Arterial, Venous Thrombosis Differ in Polycythemia Vera
- Distinct Patterns of Shiny White Streaks Strong Indicator of Melanoma
- Survival Outcomes in Relapsed Hepatocellular Carcinoma Improved With Cabozantinib
- Pertuzumab Regimen Approved for Adjuvant, Neoadjuvant Therapy in Specific Breast Cancers
- Common Oncologic Emergencies That Occur With Multiple Myeloma
- Artificial Sweeteners and Cancer Risk (Fact Sheet)
- Blueberry Extract May Boost Efficacy of Radiotherapy for Cervical Cancer
- Dietary Estrogens Reduced Efficacy of Novel Breast Cancer Therapy
- When There Are No Words: Interpreting Patients' and Families' Subtle Messages
- Depression Predictive of Poor Survival Outcomes in Head and Neck Cancer
- Nearly One Third of Veterans Report Current Tobacco Use
- Priority Review of New Drug Application Granted to Apalutamide for CRPC
- Partial Response Achieved With Atezolizumab, Cobimetinib in Pretreated CRC
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|